Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 A size standard for pharmacokinetics.

Literature DB >> 8743333

A size standard for pharmacokinetics.

N H Holford¹.

Abstract

Mesh：

Year: 1996 PMID： 8743333 DOI： 10.2165/00003088-199630050-00001

Source DB: PubMed Journal: Clin Pharmacokinet ISSN： 0312-5963 Impact factor: 6.447

× No keyword cloud information.

5 in total

1. A formula to estimate the approximate surface area if height and weight be known. 1916.

Authors: D Du Bois; E F Du Bois
Journal: Nutrition Date: 1989 Sep-Oct Impact factor: 4.008

2. Input from the deep south compartment. A personal viewpoint.

Authors: N H Holford
Journal: Clin Pharmacokinet Date: 1995-09 Impact factor: 6.447

3. Pharmacokinetics of acridine-4-carboxamide in the rat, with extrapolation to humans.

Authors: J W Paxton; D Young; I G Robertson
Journal: Cancer Chemother Pharmacol Date: 1993 Impact factor: 3.333

4. Interspecies scaling of tebufelone pharmacokinetic data and application to preclinical toxicology.

Authors: C A Cruze; G R Kelm; M P Meredith
Journal: Pharm Res Date: 1995-06 Impact factor: 4.200

5. A new extrapolation method from animals to man: application to a metabolized compound, mofarotene.

Authors: T Lave; A H Schmitt-Hoffmann; P Coassolo; B Valles; G Ubeaud; B Ba; R Brandt; R C Chou
Journal: Life Sci Date: 1995 Impact factor: 5.037

5 in total

202 in total

Review 1. Glucuronidation in humans. Pharmacogenetic and developmental aspects.

Authors: S N de Wildt; G L Kearns; J S Leeder; J N van den Anker
Journal: Clin Pharmacokinet Date: 1999-06 Impact factor: 6.447

Review 2. Common errors of drug administration in infants: causes and avoidance.

Authors: B J Anderson; J F Ellis
Journal: Paediatr Drugs Date: 1999 Apr-Jun Impact factor: 3.022

3. A model for size and age changes in the pharmacokinetics of paracetamol in neonates, infants and children.

Authors: B J Anderson; G A Woollard; N H Holford
Journal: Br J Clin Pharmacol Date: 2000-08 Impact factor: 4.335

4. Integrated semi-physiological pharmacokinetic model for both sunitinib and its active metabolite SU12662.

Authors: Huixin Yu; Neeltje Steeghs; Jacqueline S L Kloth; Djoeke de Wit; J G Coen van Hasselt; Nielka P van Erp; Jos H Beijnen; Jan H M Schellens; Ron H J Mathijssen; Alwin D R Huitema
Journal: Br J Clin Pharmacol Date: 2015-05 Impact factor: 4.335

Review 5. Prediction of hepatic metabolic clearance based on interspecies allometric scaling techniques and in vitro-in vivo correlations.

Authors: T Lavé; P Coassolo; B Reigner
Journal: Clin Pharmacokinet Date: 1999-03 Impact factor: 6.447

6. Model-based approach for optimization of atazanavir dose recommendations for HIV-infected pediatric patients.

Authors: Ying Hong; Kenneth G Kowalski; Jenny Zhang; Li Zhu; Mariaarantxa Horga; Richard Bertz; Marc Pfister; Amit Roy
Journal: Antimicrob Agents Chemother Date: 2011-09-19 Impact factor: 5.191

7. Target concentration intervention is needed for tobramycin dosing in paediatric patients with cystic fibrosis--a population pharmacokinetic study.

Authors: Stefanie Hennig; Ross Norris; Carl M J Kirkpatrick
Journal: Br J Clin Pharmacol Date: 2007-11-08 Impact factor: 4.335